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Most of the hypomorphic Prep1i/i embryos (expressing 3–10% of the Prep1 protein), die between E17.5 and P0, with profound anemia, eye
malformations and angiogenic anomalies [Ferretti, E., Villaescusa, J.C., Di Rosa, P., Fernandez-Diaz, L.-C., Longobardi, E., Mazzieri, R., Miccio,
A., Micali, N., Selleri, L., Ferrari G., Blasi, F. (2006). Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx
and Meis proteins and a pleiotropic embryonic phenotype. Mol. Cell. Biol. 26, 5650–5662]. We now report on the hematopoietic phenotype of
these embryos. Prep1i/i fetal livers (FL) are hypoplastic, produce less common myeloid progenitors colonies (CFU-GEMM) in cytokine-
supplemented methylcellulose and have an increased number of B-cells precursors that differentiate poorly. Prep1i/i FL is able to protect lethally
irradiated mice only at high cell doses but the few protected mice show major anomalies in all hematopoietic lineages in both bone marrow (BM)
and peripheral organs. Prep1i/i FL cells compete inefficiently with wild type bone marrow in competitive repopulation experiments, suggesting
that the major defect lies in long-term repopulating hematopoietic stem cells (LTR-HSC). Indeed, wt embryonic expression of Prep1 in the aorta–
gonad–mesonephros (AGM) region, fetal liver (FL), cKit+Sca1+Lin−AA4.1+ (KSLA) cells and B-lymphocytes precursors agrees with the
observed phenotype. We therefore conclude that Prep1 is required for a correct and complete hematopoiesis.
© 2007 Elsevier Inc. All rights reserved.Keywords: Homeobox; Prep1; Hematopoiesis; Hematopoietic stem cells; Repopulating activityIntroduction
The function of Hox cofactors Pbx1, Meis1 and Prep1 is
directly linked to hematopoiesis and leukemia. Pbx1 was
identified since in pre-B leukemia it was translocated at the
C-terminus of the E2A transcription factor (E2APbx1) (Kamps
et al., 1990; Nourse et al., 1990). Ablation of the Pbx1 gene in
mouse causes an embryonic lethal phenotype with severe⁎ Corresponding author. IFOM (FIRC Institute of Molecular Oncology), via
Adamello 16, Milano 20139, Italy. Fax: +39 02 2643 4844.
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doi:10.1016/j.ydbio.2007.08.031homeotic malformations, hypoplasy (or absence) of many
organs, but also lymphoid, myeloid and erythroid deficiencies
(Selleri et al., 2001; Dimartino et al., 2001; Sanyal et al.,
2007). Likewise, while Meis1 (and Hoxa9) overexpression
causes leukemia in mice (Fujino et al., 2001; Nakamura et al.,
1996; Schnabel et al., 2000; Wang et al., 2006), Meis1 ko
embryos show ophthalmic and angiogenic anomalies and are
deficient in all hematopoietic lineages including LTR-HSC
(Hisa et al., 2004; Azcoitia et al., 2005). An embryonic lethal
hypomorphic Prep1 mutant (Prep1i/i), which produces 3–10%
of the normal Prep1 protein level, show hypoplasy of most
organs, anemia, eye malformations and angiogenic anomalies
(Ferretti et al., 2006). Some Prep1i/i mice escape embryonic
death but adult mice show a defective T cell development
(Penkov et al., 2005).
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sub-family, Prep1 and Prep2, bind the amino terminus of all
Pbx proteins (Moens and Selleri, 2005). Prep1 was identified
as a stable interactor of Pbx proteins (Berthelsen et al.,
1998a), controls the half-life of Pbx1, Pbx2 and Meis1 and
the expression of Pbx3, Pbx4, Meis2 and Meis3 genes
(Longobardi and Blasi, 2003; De Florian et al., 2004; Ferretti
et al., 2006). Prep and Meis proteins contain homologous,
conserved Pbx-interacting-motifs (Shen et al., 1997; Knoep-
fler et al., 1997; Berthelsen et al., 1998b) and all of them are
therefore expected to bind to Pbx. Prep (or Meis) and Pbx
can form trimeric complexes with anterior Hox proteins
required for the expression of specific genes (Jacobs et al.,
1999; Ryoo et al., 1999; Ferretti et al., 2000, 2005; Berkes et
al., 2004).
During development, blood cells are derived from the
mesodermal layer of the embryo through an inductive, still not
totally understood process. Throughout mouse embryogenesis,
blood cells are generated sequentially from several distinct
vascular tissues. These include the yolk sac blood islands
(E7.5–E11), which produce blood cells with erythroid and/or
myeloid potential, the intraembryonic AGM (E10–E11), and
finally the FL (E11/12–birth). At birth, the BM becomes the
major hematopoietic tissue (Dzierak and Medvinsky, 1995;
Orkin, 2000; Choi, 2002; Bertrand et al., 2005).
Several key transcription factors are required at different
stages of hematopoiesis and some can switch the lineage
phenotype of cells in which they are introduced. In this way,
progenitor cells can be reprogrammed, since not only the nature
but also the level of expression of these regulators is important in
the choice of lineage (Orkin, 2000). The erythropoietic
deficiency of Prep1i/i embryos with the reduction of cMyb-
positive cells and T cells' impairment in adult Prep1i/i mice
(Penkov et al., 2005; Ferretti et al., 2006) suggests that Prep1
might be involved more deeply in hematopoiesis, affecting
common progenitors or stem cells.
In this paper, we show that, in addition to the previously
described deficiency in erythropoiesis and T cell development
(Penkov et al., 2005; Ferretti et al., 2006), Prep1i/i hypo-
morphic embryos are also deficient in B-lymphoid differentia-
tion. We also show that Prep1i/i FL cells fail to compete (0.5%)
with wild type in competitive repopulation assays, in
essentially all hematopoietic lineages. Moreover, we show
that Prep1 is expressed in KSLA and B-cells progenitors, and
by cells located in embryonic hematopoietic regions that co-
express markers of hematopoietic stem/progenitors cells. These
data show that Prep1 is required for embryonic hematopoiesis
and suggest that in its absence active long-term repopulating
hematopoietic stem cells (LTR-HSC) are decreased in activity
and/or in number.Materials and methods
Prep1 targeting
Prep1imice and embryos, as well as the PCR genotyping strategy, have been
described (Penkov et al., 2005; Ferretti et al., 2006).Antibodies
Anti-Pbx1b and Pbx2 antibodies were obtained from Michael Cleary. A
commercial anti-Prep1 monoclonal antibody (Upstate Biotechnology, Upstate
House, Dundee, UK) was used in some experiments. Polyclonal anti-Prep1
antibodies were described previously (Berthelsen et al., 1998b).
Radioprotection assay
CD45.1+ C57BL/6J (Jackson Labs., Ann Arbor, MI) recipient mice
(6–8 weeks old) were lethally irradiated (1100 cGy delivered in a single dose)
using an X ray source (150 kV, 11.9 mA). Single-cell suspensions from
CD45.2+ E14.5 wt, heterozygous Prep1+/i or homozygous Prep1i/i FL were
prepared by passage through a cell strainer (40 μm nylon) and graded
numbers of cells were transplanted by injection into the tail vein of irradiated
recipients. After transplantation, recipient mice were maintained on antibiotic
water containing neomycin sulfate (0.016 g/L). The survival of mice was
monitored daily for 30 days and subsequently less frequently for 8 months
after transplantation.
Competitive repopulation assay
We transplanted 6- to 8-week-old lethally irradiated CD45.1+ C57BL/6J
mice with a mixture of cells. Competitor cells (200,000 per mouse) were
obtained from the bone marrow of a double positive CD45.1+/CD45.2+
mouse; 150,000, 300,000 or 500,000 immunologically labeled (CD45.2+)
donor (wt or Prep1i/i) FL cells were mixed to the competitor cells and
injected into irradiated mice. A total of 6 mice was used per genotype and
dose (i.e. a total of 36 mice). After about 28 weeks the blood was withdrawn
from the tail vein and the cells tested for their surface antigens by flow
cytometry (CD45 to distinguish donors and host cells, and other markers to
distinguish cell lineages). The antibodies are described below. Calculation of
RU (repopulating units) was performed as described (Ema and Nakauchi,
2000).
Flow cytometry analysis of LTR-HSC in FL and cell sorting
In FL, the AA4.1+, cKit+, Sca1+, Lin− cells were sorted to study the
HSC-enriched sub-population, and the cKit+ population for in vitro B cell
assays. For peripheral blood analysis, erythrocytes were removed from
peripheral blood using lysis buffer (0.15 M NH4Cl, 10 mM KHCO3,
0.1 mM EDTA, pH 7.2–7.4). After blocking of specific binding with
antibodies to CD16/CD32 (Pharmingen, San Diego, CA), the following
antibodies were used in cytofluorimetry: PE-conjugated anti-mouse CD45.1
and biotinylated anti-mouse CD45.2 (Pharmingen, San Diego, CA),
Tricolor-conjugated streptavidin (Caltag Laboratories, Burlingame, CA,
USA).
For flow cytometry analysis of fetal liver cells, cKit, AA4.1, Ter119,
CD71, Sca-1 and IL-7R antibodies were from Pharmingen (San Diego, CA).
For bone marrow, lymph nodes or spleen cells, PE-conjugated rat anti-mouse
Sca-1 (Pharmingen, San Diego, CA), the Lin cocktail of FITC-conjugated
antibodies for lineage markers (B220, Gr-1, Mac-1, Ter119 and CD3,
Pharmingen, San Diego, CA) were used. For the analysis of in vitro pro-
pagated B cells, we used PE-Cy5-conjugated anti-B220 (Pharmingen, San
Diego, CA) and FITC-conjugated anti-IgM (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA).
Flow cytometry analysis of B cell progenitors and cell sorting
FL cells from 14.5 dpc embryos were stained with the following antibodies
by standard procedures after blocking the non-specific binding by anti-mouse
CD16/CD32 (Pharmingen, San Diego, CA): PE-conjugated anti-mouse CD43,
APC-conjugated anti-mouse B220 (Pharmingen, San Diego, CA), FITC-
conjugated CD24 (Pharmingen, San Diego, CA). The CD43+/B220+/CD24−
(precursor), CD43+/B220+/CD24+ (proB) and the CD43−/B220+ cells from
14.5 dpc FL were then sorted to evaluate the expression level of Prep1 mRNA
during B cell development.
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E14.5 FL cells. Sorted cKit+ cells (4×103/well) were seeded into 6-well plates
containing a confluent monolayer of OP9 cells. All cocultures were performed in
the presence of 5 ng/ml IL-7 and 5 ng/ml Flt3L. Cells were collected by forceful
pipetting after 12 days, counted and analyzed by FACS. An anti-CD45 antibody
was used to discriminate hematopoietic from stromal cells.
Colony-forming assays
Colony assays were carried out incubating 2.5×104 Prep1+/+, Prep1+/i or
Prep1i/i FL single-cell suspensions in 1 ml methylcellulose enriched with
recombinant cytokines (Methocult GF M-3434, Stem Cell Technologies,
Vancouver, Canada), in triplicate. CFU-GM and BFU-E were scored after
10 days of culture. CFU-GEMM (granulocytes, erythrocytes, megakaryocytes,
macrophages CFU) after 13 days.
Immunofluorescence and immunohistochemistry
For whole-mount immunofluorescence, embryos or dissected dorsal aorta
were fixed with methanol/DMSO (4:1), blocked overnight at 4 °C in blocking
solution (3% BSA, 5% FBS, 20 mMMgCl2, 0,3% Tween-20, in PBS containing
5% goat serum) overnight and then incubated for 1 h at room temperature with
anti-Prep1 antibody (from Upstate Biotechnology, Upstate House, Dundee, UK)
in 1:100 dilution, or with biotinylated anti-cKit (1:50 dilution, from Pharmingen,
San Diego, CA). Embryos were then washed with PBS 0.1% Triton X-100, and
incubated for 2 h at room temperature with secondary antibodies (anti-mouse
Cy3-conjugated and anti-rat Cy5-conjugated, 1:400 dilution), washed and fixed
with paraformaldehyde 2% for 5 min in PBS, and washed again extensively.
Finally, they were incubated with biotinylated anti-Sca1 (1:50 dilution, from
Pharmingen, San Diego, CA), washed and incubated with streptavidin–FITC
(Pierce, Perbio), ending by an incubation with DAPI for 5 min, and final washes.
Then, embryos were mounted in PBS–Glicerol (50%) and analyzed by confocal
microscopy.
For immunohistochemistry, FL from E14.5 embryos were fixed, dehydrated
and embedded in paraffin. Deparaffinated sections (7 μm) were blocked as for
immunofluorescence, and incubated for 1 h at room temperature with anti-Prep1
antibody (from Upstate) in 1:100 dilution, or with anti-Ter119 (1:50 dilution,
from Pharmingen, San Diego, CA), washed in PBS Triton X-100 (0.5%), and
incubated with biotinylated secondary anti-mouse or anti-rat IgG (Vectastain®
ABC Kit, Vector Laboratories, Inc.) following manufacturer's protocol. Finally,
Ter119 was detected with DAB substrate kit and Prep1 with Vector Red Alkaline
Phosphatase Substrate Kit I (Vector Laboratories, Inc.).
RNA extraction, RT–PCRs and two-step PCR from B-lymphoid
progenitors and KSLA cells RNA
Total RNA was extracted (see below) from sorted FL cells according to
standard procedures using the Quiagen kit. Ten ng of total RNA was
retrotranscribed with the Invitrogen Superscript Choice System protocol using
random examers for first strand cDNA synthesis. Amplification of specific
amplicons were obtained with the following primers pair:
PREP-1for, 5-ACAGACGCTAAGTATAGACAG-3
PREP-1rev, 5-AATCTGCTGGGATTGCACA-3
Amplification consisted in a first denaturation step at 97 °C for 2 min
followed by 38 cycles each consisting of a denaturation step at 97 °C for 30 s, an
annealing step at 60 °C for 30 s, and an extension step at 72 °C for 30 s. To end
the reaction, an extension step of 10 min at 72 °C was used. 2 μl of this first step
of amplification were then used in a second PCR that was performed basically as
the first, but in 45 cycles. The identification of the ∼500 bp amplified fragment
as Prep1 mRNAwas confirmed by restriction enzyme mapping with the AAT2
and DDE1 enzymes.
To detect Prep1 mRNA from KSLA cells, total RNA was isolated and
reverse-transcribed from 150 sorted wt embryo cells as described above. The
RNA was concentrated using a Speed Vac Concentrator (Labconco). All the
RNAwere retrotranscribed in a single reaction using SuperScript™ First-StrandSynthesis System (Invitrogen, Carlsbad, CA, USA) and random primers. For
PCR amplification, the specific primers for Prep1 have been described above.





Conditions for PCR amplification were the same for all the primers:
denaturation at 94 °C for 5 min, 35 cycles at 94 °C (15 s), 60 °C (30 s), 72 °C for
30 s, with a final elongation step at 72 °C for 10 min.
Statistical analysis
The significance of the data is calculated with homoscedastic two-tailed
Student's t-test. However, significance did not change with unequal variance t-
test.Results
Prep1i/i FL is deficient in B-lymphoid lineage maturation
The phenotype of Prep1i/i embryos has variable penetrance
and expressivity, but includes a striking pallor, smaller size,
edema, anemia and a smaller liver spot that are observed in
about 60% of the embryos (Ferretti et al., 2006). We also
previously observed that in the presence of erythropoietin and
in the absence of other cytokines, the growth of CFU-E and
BFU-E colonies in methylcellulose was strongly reduced in
Prep1i/i FL (Ferretti et al., 2006). The anemic phenotype was
found in many but not all embryos at E14.5–16.5 and is in
agreement with the death in utero of three quarters of the
Prep1i/i embryos between E17.5 and P0 (Ferretti et al., 2006).
In order to analyze other hematopoietic lineages, we tested
the progenitor activity of Prep1i/i FL cells, carrying out
colony-forming assays in cytokine-enriched (SCF, IL-3, IL-6,
EPO) methylcellulose medium. At E14.5, the Prep1i/i FL was
generally much smaller than wt (see total cell number in
Table 1). The total number of colonies formed, after plating
equal number of cells, by Prep1i/i FL cells was reduced but
the result was not statistically significant. Also the number of
CFU-GM and BFU-E colonies in the three phenotypes
showed a trend towards a decrease in Prep1i/i but did not
reach statistical significance. However, CFU-GEMM colonies
(more immature common myeloid progenitors, granulocyte,
erythrocyte, macrophage and megakaryocyte) were reduced to
less than half compared to both wt and heterozygous FL
(p=0.02 or 0.01, respectively). The data of Table 1 were
obtained from a total of 5 wt, 12 Prep1+/i and 6 Prep1i/i
embryos.
We then investigated whether single-lineage progenitors
were affected. B cell lineage progenitors were studied by flow
cytometry using the Il7R, Sca1 and cKit markers (Table 2).
While the percentage of CMP (including also GMP and MEP,
IL7R−, cKit+, Sca1−) in the FL was comparable in the three
phenotypes, the population enriched in more undifferentiated
progenitors (p=0.03) (IL7R−, cKit+, Sca1+) and the CLPs
(p=0.02) (IL7R+, cKitlo, Sca1lo) were in fact relatively
Table 1
Colony-forming activity of E14.5 FL cells in semi-solid methylcellulose medium
Genotype N a No. cells/FL b CFC/25,000 c CFU-GMc BFU-Ec CFU-GEMMc
+/+ 5 26.2±5.7
(100%)
31.6±5.48 8.00±3.69 20.2±4.21 3.44±1.41
+/i 12 17.8±5.2
(67.9%)
35.6±6.00 7.94±2.97 23.7±4.26 3.93±1.86
i/i 6 10.9±5.2
(41.6%)
26.7±6.31 6.92±3.51 18.3±2.72 1.48±0.85
p-value i/i vs. +/i 0.02 0.01 0.52 0.01 0.01
p-value i/i vs. +/+ 0.001 0.21 0.62 0.39 0.02
a Number of independent Prep1i/i, Prep1+/i and Prep1+/+ embryos analyzed.
b Number of fetal liver cells×10−6±standard deviation. The number in brackets in the lower row represents the percentage (100% for wt FL).
c Twenty-five thousand FL cells of the indicated genotype were plated in semi-solid methylcellulose medium supplemented with SCF, IL-3, IL-6 and EPO and the
number of colonies formed scored after 10 days (CFU-GM and BFU-E) or 13 days (CFU-GEMM). The results represent the average number of colonies/plate±
standard deviation scored from the indicated number of experiments, each carried out in triplicate. The p-values were calculated by the homoscedastic t-test (see
Materials and methods).
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in B-cells progenitors maturation in the Prep1i/i FL.
We also studied whether Prep1i/i cells were impaired in their
myeloid and B lymphoid differentiation, as was previously
shown for the T (Penkov et al., 2005) and erythroid (Ferretti et
al., 2006) lineages, performing in vitro differentiation experi-
ments in sorted cKit+ FL cells. No difference in neutrophils and
macrophage differentiation was observed by culturing cells with
recombinant mG-CSF or mM-CSF (data not shown).
We then analyzed B cells differentiation by culturing four
thousand sorted cKit+ FL cells of the three genotypes in vitro on
the OP9 stromal cell line for 12 days (Table 3). At this time,
Prep1i/i cells produced a higher percentage of B220+ cells (in
agreement with the higher proportion of CLP in FL, Table 2),
and a normal percentage of B220+IgM+ cells with respect to wt
and heterozygous embryos. Since the percentage of the B220+
cells was higher in the Prep1i/i phenotype, this resulted in a
decreased percent of differentiation to the IgM+ stage (Table 3).
Therefore, this experiment also points to an accumulation of
precursors and a delayed B cell differentiation in Prep1i/i cells.
Finally, we examined the B cells progenitors at E14.5 in the
FL of Prep1i/i embryos using flow cytometry with B220, CD43
and CD24 markers. Overall, the average number of very
immature progenitors (B220+CD43+CD24− ), pro-B
(B220+CD43+CD24+) and pre-B (B220+CD43−CD24+) cells
was lowest in the wt, intermediate in the heterozygous and
highest in the homozygous Prep1i/i embryos. However, whileTable 2
CMP and CLP cells in the E14.5 Prep1i/i fetal liver a
Embryos
genotype




wt 12 100±9.2 100±6.3 100±4.4
i/+ 15 93.5±17.7 92.5±7.9 110±18.1
i/i 8 172.3±34.5 100.9±17.4 200±50
p-value c 0.03 0.95 0.02
a Proportion of cells with the indicated phenotype divided by the total FL
cellularity and related to the wt embryos, in which the value is set=100. Data
represent the mean±SEM.
b Number of embryos FL analyzed.
c Student's t-test (wt vs. i/i).the data from wt and heterozygous embryos fell into a narrow
range, those from the homozygous Prep1i/i embryos were very
different from each other. In particular, the percent of Pro-B in
the three different Prep1i/i embryos was 2.5, 2.7 and about 37%
of the total, while Pre-B represented 1.5%, 1.5% and 8.7% (data
not shown). Hence, one of the embryos showed a strong block
of differentiation at the Pro-B to Pre-B stage. In any case, the
values of the other embryos were always higher than in the
heterozygous or wt embryos. The same type of variability was
previously observed in a similar analysis of the erythroid
differentiation in Prep1i/i embryos, in which again only a
minority of the embryos showed a block of differentiation
(Ferretti et al., 2006).
These three experiments, although performed on different
embryos and directed to testing different aspects of B cells
differentiation, are in essential agreement with each other and
show that there is a delay/block of B cell differentiation,
possibly at the Pro-B to Pre-B stage.
To support the function of Prep1 in B cells differentiation, we
have analyzed the presence of Prep1 mRNA in the B-cells
progenitors, sorting Pro-B, Pre-B and earlier progenitors from
wt FL by FACS, and determining the presence of Prep1 mRNA
by RT–PCR (see Materials and methods). The results show that
Prep1 mRNA is present in very early precursors, Pro-B and Pre-
B cells (Fig. 4A). The identity of the RT–PCR products was
determined by restriction enzyme digestion (with AAT2 and
DDE1 enzymes) of the band shown in Fig. 4A (data not shown).
Prep1i/i embryos are defective in hematopoietic stem cells
Hematopoietic stem cells are capable of repopulating the
bone marrow of a lethally irradiated mouse. We performed
repopulation experiments in lethally irradiated wt CD45.1+ host
mice transplanting different numbers of donor CD45.2+ FL cells
(250,000 to 2 million) from Prep1+/+, heterozygous Prep1+/i or
homozygous Prep1i/i embryos. Mice surviving at 30 days with
wt and Prep1i/i FL reached almost the same degree of chimerism
(not shown) (87% vs. 95%, not shown). Fig. 1 shows the
differential ability of FL cells to short-term protect irradiated
mice. Indeed, Prep1i/i FL cells were much less effective in their
Table 3
In vitro B-cell differentiation of E14.5 FL cells plated onto the OP9 stromal cell line
Embryos' genotype n Total B220+ (×10−3) B220+ (%) Total B220+ IgM+ (×10−3) B220+ IgM+ (%) IgM+ in the B220+ subset (%)
wt 7 801±147 34.68±2.71 17.31±2.76 0.94±0.21 2.78±0.64
+/i 6 958±249 44.02±4.4 22.6±5.22 1.44±0.56 3.68±1.5
i/i 4 2091±497 80.98±1.09 18.8±6.7 1.01±0.33 1.24±0.42
p-value a 0.07 b0.001 0.81 0.88 0.07
Four thousand sorted c-Kit+ FL cells were cultured on the OP9 stromal cell line for 12 days, and then the cells were analyzed by cytofluorimetry for the indicated
markers. Data represent the mean±SEM of the number (or of the percentage) of cells with the given phenotype.
a Student's t-test (wt vs. i/i).
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compiles the data obtained from a total of 98 mice transplanted
with various doses of FL cells of the various genotypes, that
suggest that Prep1i/i FL contain fewer, or less functional, short-
term repopulating progenitors (STR-HSC). Indeed, only at the
highest cell dose (2 million cells per animal), Prep1i/i FL cells
protected as efficiently as wt or heterozygous, while with
250,000–500,000 cells the protection activity was about one
fourth than wt or heterozygous cells (Fig. 1 and data not shown).
In any case, those mice still alive at 30 days lived for at least
8 months (not shown). This experiment allows us to conclude
that while short-term protective activity is impaired in Prep1i/i
FL cells, the long-term repopulation activity may still be normal
but the number or activity of LTR-HSC may be reduced.
To test this point, we sacrificed the long term protected mice
of the above experiment 6–8 months after transplantation and
studied their BM and peripheral hematopoietic organs: the data
indicated an overall deficient repopulating activity of Prep1i/i
FL cells. In BM (Table 4) and spleen (data not shown), the
number of Prep1i/i donor-derived cells (i.e. CD45.2+) of the
B-lineage (B220+, p=0,008) and myeloid lineage (Gr1+ and
Mac1+, p=0.04) was reduced 30% to 50% with respect to wt.
No difference in donor contribution to Ter119+ cells was
observed in either BM or spleen. The total number of cells in
BM was decreased about 20% in the Prep1i/i FL cells
transplanted mice. The deficient repopulation in BM thus
affects mostly B (57% of wt) and less the myeloid (75% of wt)Fig. 1. Repopulation activity of Prep1i/i E14.5 FL cells. Short-term (30 days)
radioprotective activity of E14.5 wt and Prep1i/i FL cells. Lethally irradiated
CD45.1+ mice were transplanted with different doses of E14.5 FL cells from
both wt and Prep1i/i CD45.2+ embryos. Survival of mice (in percent) is shown at
various cells doses of transplanted cells, 30 days after transplantation. Each
single point represents the average of several mice, indicated by “n”. The
phenotypes of the transplanted cells are indicated.population. In spleen and lymph nodes, in addition, Prep1i/i
CD8+/TCRαβ+ and CD4+/TCRαβ+ T-lymphocytes were
reduced by two thirds (not shown). This agrees with our pre-
vious data showing a similar deficiency in donor Prep1i/i FL
cells in thymus with accumulation of double positive T-cells
and a decrease in single positive CD4+ and CD8+ cells (Penkov
et al., 2005). Peripheral blood analysis also showed a decreased
number of mature CD4+ and CD8+ T-cells, an almost normal
number of B220+ cells, and decreased Gr1+ as well as Ter119+
cells of Prep1i/i (i.e. CD45.2+) origin (Table 5). These data
show that repopulated mice are deficient in most hematopoietic
lineages.
We also analyzed the colony-forming activity of BM cells
from 10 transplanted mice in cytokine-supported methylcellu-
lose colony assays. BM from Prep1i/i FL cells-transplanted
mice formed a normal number of CFU-GM and BFU-E and a
much smaller number of common myeloid progenitor colonies
(CFU-GEMM, 33% of wt, p=0.059), as observed (Table 1)
with embryonic cells. The total colony-forming activity of the
bone marrow (two femurs and two tibiae) was reduced by 10%
(not shown) but CFU-GEMM colonies were reduced about
fourfold (Table 6).
The above results suggest that the Prep1i/i FL has a deficient
activity of both STR-HSC (Fig. 1) as well as LTR-HSC (Tables
4–6). We therefore used flow cytometry to sort highly enriched
hematopoietic stem cells from the E14.5 FL. We determined the
number of cells displaying cKit+Sca1+Lin− AA4.1+ (KSLA
cells) surface properties, after gating out of Ter119+ (Hsu et al.,
2000). In the two tested embryos, the absolute number of KSLA
cells per E14.5 Prep1i/i FL was reduced four fold compared to
wt (3500 vs. 13,500) but in both cases KSLA cells were about
0.06% of the total FL cells. Since KSLA cells are highly
enriched in LTR-HSC (Hsu et al., 2000), this result does not
support a specific reduction of these cells in Prep1i/i FL.
However, although highly enriched in LTR-HSC, KSLA cells
cannot be assimilated to LTR-HSC. Hence our data suggest that
the deficient repopulation activity of Prep1i/i FL may not be due
to a decrease in the absolute number of LTR-HSC but rather to
their lower activity (survival or other).
If Prep1 has a role in hematopoietic stem cells physiology, it
should be expressed in KSLA cells. Therefore, we examined the
expression of Prep1 in these cells preparing total RNA and
performing RT–PCR on the sorted cells. As shown in Fig. 4B,
these cells produced Prep1 (and Pbx1b) mRNA.
To test the hypothesis of a hematopoietic stem cells
deficiency in the Prep1i/i embryos, we performed competitive
Table 4
Analysis of the bone marrow of mice transplanted with Prep1i/i E14.5 FL cells shows a deficient long-term repopulation activity
Donor N a CD45.2+ B220+ (×106) b CD45.2+ Gr1+/Mac1+ (×106)b CD45.2+ Ter119+ (×106)b Total cell number (×106)b
+/+, +/i 11/57 18.1±6.08 41.1±11.06 40.0±13.9 111±19.7
i/i 7/16 10.3±4.05 30.5±8.5 43.2±7.37 89.4±17.7
p-value 0.008 0.04 0.53 0.03
Lethally irradiated CD45.1+ mice were transplanted with 200,000 to 2,000,000 CD45.2+ FL cells of the indicated donor genotype. Cell suspensions of the bone
marrow of surviving mice (mostly transplanted with 2 million cells in the case of the Prep1i/i FL) were analyzed at 6–8 months after transplantation. A total of 98 mice
were transplanted with wt and heterozygous (total of 11 embryos) or homozygous Prep1i/i FL cells (7 individual embryos), and 73 survived. The data are taken from
the animals of the experiment shown in Fig. 1.
a The first number shows the number of embryonic FL employed for each genotype. The second, the total number of surviving mice examined. Data are taken
from the surviving mice of the experiment shown in Fig. 1. The p-values were calculated by the homoscedastic t-test (see Materials and methods).
b Data show the average number of CD45.2+ cells expressing the different cell surface markers scored by flow cytometry±standard deviation. Each measurement
was performed in triplicate.
329P. Di Rosa et al. / Developmental Biology 311 (2007) 324–334repopulation experiments transplanting lethally irradiated
CD45.1+ mice with a combination of cells: 200,000 competitor
BM cells from wt doubly labeled CD45.1+/CD45.2+ mice,
along with 150,000, 300,000 or 500,000 E14.5 FL donor cells
from either CD45.2+ wt or Prep1i/i littermate embryos. The
E14.5 FL donor cells were derived from 1 wt and 1 Prep1i/i
embryo (total number of cells/liver: 27 and 8 million, res-
pectively). Each cell dose was transplanted into a total of 6 mice
per group and the surviving mice (32/36) were analyzed about
28 weeks post-transplantation. Peripheral blood from the
transplanted mice was analyzed by flow cytometry for the
expression of the CD45.1 and CD45.2 markers, and the relative
contribution of the three populations (assessed by the number of
CD45.1+/CD45.2+ competitor, and CD45.1−/CD45.2+ donor
cells), was used to evaluate chimerism. The (very low)
contribution of the CD45.1+ host cells (equal in all mice) was
not included in the calculations. The data from all cell doses
were pooled for each genotype and expressed as RU per 105
transplanted cells. Repopulating units (RUs) were calculated
from the percentage of CD45.2+ versus CD45.1+CD45.2+
circulating cells (Ema and Nakauchi, 2000), as indicated in the
legend to Table 7. The data show that Prep1i/i FL had about
fivefold less repopulating activity than wt (2.18 vs. 10.8,
p=0.0001). Since the total number of FL cells in Prep1i/i was
about one third than in wt, the overall repopulating activity of
the Prep1i/i FL was reduced over sixteen fold compared to wt
(174 vs. 2880 RU). This decrease is much higher than that of
KSLA cells (see above) and therefore may suggest that Prep1i/i
FL has a major deficiency in the activity, rather than number, of
LTR-HSC.Table 5
Peripheral blood analysis of mice transplanted with Prep1i/i FL a






i/+, +/+ 7/42 13,140±4468 96.1±1.61 1198±499.4 947±
i/i 9/18 8227±2816 86.1±5.21 561±395 244±
p-value 0.02 0.0001 0.015 0.000
The p-values were calculated by the homoscedastic t-test (see Materials and method
a CD45.1+ mice were lethally irradiated and transplanted with different doses of F
transplantation.
b The first number indicates the embryonic FL employed per genotype; the seco
c Number of cells/ml blood expressing the CD45.2+ cell surface marker.
d This column shows the total number of Ter119+ cells (CD45.1+ plus CD45.2+We also analyzed peripheral blood for the competitive
repopulating activity of different hematopoietic lineages. As
shown in Table 8, Prep1i/i FL-transplanted mice had a
consistently lower number of RU than wt, in agreement with
the overall lower repopulating activity. The statistical signifi-
cance was high for the lymphoid lineage, but represented a trend
for the myeloid and erythroid lineages. Of particular interest,
and in agreement with the previously observed T cells de-
ficiency of Prep1i/i adult mice (Penkov et al., 2005), Prep1i/iFL
competed 16-fold less for the reconstitution of the CD4+
T-lineage (p=0.0001) and 6-fold less for the CD8+ T-cells
(p=0.0002). Moreover, they competed 3- to 4-fold less for the
B-cells (p=0.008) reconstitution.
In conclusion, despite the variability among Prep1i/i
embryos, all data indicate that the reduction of Prep1 is
accompanied by a profoundly deficient hematopoiesis, in
particular in the B-lymphoid lineage.
Expression of Prep1 in embryonic hematopoietic stem/
progenitor cells
The multiple-lineage phenotype of the Prep1i/i embryos
points out that the defect may lie in LTR-HSC or in early
hematopoietic progenitors. We therefore used immunofluores-
cence and immunohistochemistry and analyzed the wt embryos
to search for Prep1 expression in active hematopoietic sites. The
AGM region at E10.5–12.5 and the FL at E14.5, are sites where
embryonic hematopoietic activity and precursors are concen-
trated (Hsu et al., 2000). At E10.5 we detected by whole-mount










349 6940±834 1867±670.2 7734±2630 7986±2699
175 5049±139 1145±235.7 3731±2074 5359±1437
3 0.16 0.017 0.005 0.048
s).
L cells of CD45.2+ mice (see Fig. 1). Analyses were performed 8 months after
nd number, the mice in which they were transplanted.
cells).
Table 6
Colony-forming activity of bone marrow cells from mice transplanted with Prep1i/i FL a
Genotype N b CFU-GM CFU-GEMM BFU-E Cells per BMc CFU-GM per BMd CFU-GEMM per BMd BFU-E per BMd
+/+ or +/i 5/10 27.7±9.75 2.03±1.45 20.4±5.43 119.6±16.1 61,023 4466 44,941
i/i 5/10 27.2±5.65 0.67±0.54 21.7±3.1 96.5±14.8 47,416 1192 38,626
p-value e 0.90 0.059 0.56 0.13 – – –
a Fifty thousand cells of the indicated genotype were plated in semi-solid methylcellulose medium and the number of colonies formed scored after 10 days (CFU-
GM and BFU-E) or 13 days (CFU-GEMM). The results represent the average number±standard deviation, of colonies/plate scored from the indicated number of
experiments (N), each carried out in triplicate on independent BM from mice transplanted with 2,000,000 of FL cells of the indicated genotype (Fig. 1). Mice were
sacrificed and analyzed 8 months after transplantation.
b Number of independent Prep1i/i, Prep1+/i and Prep1+/+ FL (2 million cells per mouse) employed for transplantation. The second number shows the total number
of mice analyzed (i.e., each FL was used for two mice).
c Total number of cells ×10−6, obtained from two femurs and two tibiae of five animals/group, in the two groups of transplanted mice.
d Calculated from the measured average values reported in the third, fourth and fifth columns.
e p-values are calculated with a paired t-test. When calculated with a homoscedastic t-test, the values (corresponding to the third, fourth and fifth columns) were
0.93, 0.08 and 0.74, respectively.
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vessels (Figs. 2A, B, D). E10.5 Prep1i/i embryos gave no
staining (not shown). In this area, Prep1 was expressed in most
cells, also expressing cKit (Figs. 2E, F). At higher magnification
(Fig. 2C), cells within the aorta were shown to co-express Prep1
with Sca1 and cKit (Figs. 2G–L), antigens commonly used to
identify HSC (Orelio et al., 2004). Thus, this experiment reveals
the presence of Prep1 in the AGM region, and its co-expression
of Prep1, Sca1 and cKit, in a large fraction of cells, in keeping
with the possibility that Prep1 is expressed by HSC.
Since Prep1i/i embryos often die of anemia, we also tested
for the co-localization of Prep1 and Ter119, a marker of
erythropoietic progenitors, in the FL. At E14.5, coronal FL
sections were analyzed by immunohistochemistry with anti-
bodies for Prep1 (red) and Ter119 (black). As shown in Fig. 3,
Prep1 was also expressed in the FL in a fraction of cells positive
for Ter119 (compare for example panels G and H), as well as in
Ter119-negative cells (panel I). We also found co-localization of
Prep1 with CD31, a marker of both hematopoietic and (mostly)Table 7
Prep1i/i FL contains a lower number of repopulation units (RU) a
n wt b RU c n Prepi/i RUc p-value d
Total RU/10−5 e 17 10.8±1.64 15 2.18±0.4 0.0001
RU/FL f 2880 174
a C57BL/6, CD45.1+ mice were lethally irradiated and then transplanted with
a combination of 200,000 BM cells (competitor cells) from double-positive
CD45.1+/CD45.2+ and different amounts of single-positive CD45.2+ donor cells
(from one E14.5 wt or Prep1i/i FL). The blood from surviving mice was drawn
after about 28 weeks, and the presence and percent of the CD45.1+ and CD45.2+
surface markers measured by flow cytometry on circulating blood cells. In the
calculation of RUs, the contribution of the CD45.1+ host was not taken into
account as it represents a small and fixed percentage (around 3%) in all mice.
b Number of transplanted mice surviving at the time of the analysis. Overall,
32 out of 36 mice survived.
c Results are presented as mean±SEM.
d The p-value was calculated with the homoscedastic t-test.
e Repopulating units. This number was calculated as percentage of circulating
CD45.2+ cells divided by percentage of circulating competitor-derived cells
(CD45.1+/CD45.2+). Each value was then normalized to 100,000 competitor
cells (Ema and Nakauchi, 2000).
f Average RUs per fetal liver. In this case, the wt FL contained 26.7 million
cells, and the Prep1i/i FL 8 million cells.endothelial cells (data not shown). These data confirm previous
data showing co-expression of Prep1 in cMyb-positive and
cKit-positive cells in the FL (Ferretti et al., 2006), and show that
Prep1 is expressed in a region of active hematopoiesis.
To finally test for the expression of Prep1 also in adult
hematopoietic stem and/or progenitor cells, we also sorted cells
from the adult bone marrow (BM) in populations enriched in
HSCs (Sca-1+/Lin−), or progenitor cells (Sca-1+/Lin+) or more
differentiated cells (Sca-1−/Lin+) (Pineault et al., 2002), and
immunoblotted nuclear and cytoplasmic extracts from 5×106
cells from each sorted population with anti-Prep1 and anti-
Pbx1b antibodies (Fig. 4C). Prep1 was found in the nuclear as
well as cytoplasmic extracts of Sca-1+/Lin− cells. In Sca-1+/Lin+
subpopulations, Prep1 was still present but mostly in cytoplas-
mic extracts, while it was almost undetectable in the Sca-1−/Lin+
subpopulation. Pbx1b was detected in the nucleus of the Sca-1+/
Lin− bone marrow cell population, as expected (Selleri et al.,
2001; Dimartino et al., 2001), but disappeared upon their
maturation to precursors and more differentiated cells.
All these data support the expression of Prep1 in the
hematopoietic compartment, both in the embryo (AGM and FL)
and in the adult (BM), in cells that represent hematopoietic stem
and/or progenitor cells.
Discussion
TALE class homeodomain transcription factors (Pbx, Prep
and Meis) are key regulators of embryonic development in allTable 8
Repopulating activity of Prep1i/i (CD45.2+) FL-repopulated mice are deficient
in all hematopoietic lineages a
Marker RU/10−5 wt RU/10−5 i/i p-value
CD8+ 3.37±0.47 0.21±0.05 0.0001
CD8− CD3+ 5.83±1.06 0.95±0.21 0.0002
Ter119+ 1.37±0.46 0.61±0.23 0.16
B220+ 9.67±2.18 2.66±0.98 0.008
Gr1+/Mac1+ 5.4±1.56 2.19±0.98 0.1
a Data were collected in the experiment illustrated in Table 7 and details are
given in the legend to Table 7, in Footnote b. Results are presented as mean±
SEM. p-values were calculated by the homoscedastic t-test.
Fig. 2. Immunofluorescence analyses of Prep1 expression in the AGM region. (A–B) Confocal expression analysis of Prep1 in whole-mount E10.5 embryos in the
region of the dorsal aorta (da) and somites (so) in wild-type embryo, showing red staining for Prep1 (B) and DAPI in blue (A). Notice the dorsal aorta and intersomitic
vessel regions showing Prep1 expression (see also scheme in gray, inside A). (C) Dissected AGM region used for whole-mount analysis. (D) Phase contrast analysis of
the region, showing schematically the aorta. (E, F) Same region as in panel D, stained for DAPI and Prep1, respectively. The square depicts the region magnified in
panels G–L. (G–L) AGM region stained with DAPI, Prep1, Sca1 and/or cKit antibodies, as indicated. Notice Sca1+cKit+Prep1+ cells inside and lining the aorta. Panel
L shows the merging of the Sca1, cKit and Prep1 staining. Magnification: A–B=40×; C, D–F=20×; G–L=63× with a zoom of 2.
331P. Di Rosa et al. / Developmental Biology 311 (2007) 324–334organisms (Moens and Selleri, 2005). While the ablation of the
Hox genes generally has a local phenotype, the ablation of some
TALE genes has a pleiomorphic, embryonic lethal phenotype
(Hisa et al., 2004; Azcoitia et al., 2005; Ferretti et al., 2006;
Selleri et al., 2001), in agreement with TALE proteins regulating
the activity of multiple Hox genes and proteins. Meis1 and
Pbx1 ko embryos die at E14.5 (1, 17, 35), Pbx3 ko at P0
(Rhee et al., 2004) while Pbx2 ko has no apparent phenotype
(Selleri et al., 2004). Among TALE genes, the Prep1 ko has the
most drastic phenotype with intra-uterine death at E7.5, i.e.
before gastrulation (Fernandez LC, Jenkins N, Copeland NG
and Blasi F, in preparation). Indeed, the analysis of the Prep1i/i
hypomorphic embryos reveals that Prep1 controls the level of
Meis and Pbx family members either at the pre- or at the post-
transcriptional stage and hence the entire TALE–Hox pathway
and the expression of at least some Hox genes (De Florian et al.,
2004; Penkov et al., 2005; Ferretti et al., 2006).
In this paper, we have shown that Prep1i/i embryos display a
major FL hypoplasy (Table 1) which affects the number of
KSLA cells, highly enriched in LTR-HSC cells (Hsu et al.,
2000). When analyzed in detail, Prep1i/i FL cells showed a
deficient proliferation of CFU-GEMM colonies in methylcellu-
lose (Table 1). Moreover, we have observed by three different
approaches that Prep1i/i FL cells have a tendency to a delayed or
blocked differentiation of the B-lymphocytes precursors (Tables2 and 3). These results are in agreement with the expression of
Prep1 in stem cells and pro-B and pre-B progenitors (Fig. 4).
The defect in hematopoietic progenitors became even more
evident when we analyzed the repopulating activity of Prep1i/i
FL cells. Indeed, the 10-fold less short-term radio-protection
(Fig. 1) agrees with the reduced number of CFU-GEMM and
with the reduced ability to differentiate of B cells progenitors.
However, even if only at high doses of Prep1i/i cells, mice were
long-term radio-protected. However, these mice showed defi-
ciencies in essentially all lineages, in peripheral blood and
hematopoietic organs (Tables 4–6). These data complement the
previously observed deficiency in erythropoiesis during the
embryonic life (Ferretti et al., 2006) and in T-cells development
of the adult Prep1i/i mice (Penkov et al., 2005). Hence Prep1i/i
embryos are deficient in the development of essentially all
lineages, possibly because of defects in the LTR-HSC. Indeed,
competitive repopulation assays (Tables 7 and 8) showed that
Prep1i/i FL cells had a lower RU activity than wt. This assay
gives no information on the actual number of LTR-HSC (Ema
and Nakauchi, 2000) as no dilution titration was carried out due
to the variable inter-embryonic penetrance and expressivity of
the Prep1i/i mutation (Ferretti et al., 2006). However, since the
percentage of Prep1i/i KSLA cells reflected the overall FL
hypoplasy, while the reduction in RUwasmuchmore drastic, the
results likely indicate a reduced activity rather than number of
Fig. 3. Immunohistochemical analysis of Prep1 expression on E14.5 FL sections. (A–F) Coronal sections of the FL showing immunohistochemistry of E14.5 FL
stained with hematoxylin and eosin (A), with secondary antibodies only (C), with antibodies Ter119 (black) (D), with antibodies against Prep1 (red) (F, I). No Ter119+
cells were detected in Glisson's capsule (gc, A). Ter119 staining is clearly located in the cytosolic membrane (D), while Prep1 shows both cytosolic and nuclear
localization (F, G). Panels E and H show a section stained with both Prep1 and Ter119 antibodies. (G–H) Coronal sections of the aorta region showing a predominantly
nuclear staining of Prep1. Ter119+Prep1+ cells are located inside aorta and in clusters located on the aorta endothelium (H), especially on the ventral side. (I)
Magnification showing a nucleated blood cell with a clear nuclear Prep1 staining. Magnification: A–C=20×; D–H=63×; I=100×.
332 P. Di Rosa et al. / Developmental Biology 311 (2007) 324–334LTR-HSC. In any case, we can conclude that Prep1 expression
is required for the proper activity of the entire embryonic
hematopoietic system. However, the lymphoid compartment
appears to be more sensitive to the Prep1 reduction. Erythroid
and myeloid lineages also tended to be affected, but theFig. 4. Prep1 (and Pbx1b) mRNAs and proteins are present in sorted FL B-cells prog
PCR analysis (see Materials and methods) in B-cells progenitors sorted from wt E14
actin expression in KSLA cells sorted from wt E14.5 FL. (C) Immunoblotting analys
Lin surface markers as indicated on top (S=Sca1, L=Lin).significance were not always statistically supported (Table 7).
However, those results may be affected by the high variability
and penetrance of the Prep1i/i phenotype; conditional targeting
studies will be required to better define the sensitivity of
individual lineages to Prep1 reduction.enitors, KSLA cells and in adult BM hematopoietic cells populations. (A) RT–
.5 FL. (B) RT–PCR analysis (see Materials and methods) of Prep1, Pbx1b and
is with Prep1, Pbx1b and actin antibodies on adult BM cells sorted for Sca1 and
333P. Di Rosa et al. / Developmental Biology 311 (2007) 324–334The deficient activity of the Prep1i/i LTR-HSC correlates
well with the expression of this gene in KSLA cells (Fig. 4), in
the embryonic hematopoietic tissues and with the co-expression
with markers of LTR-HSCs or progenitors (Figs. 2 and 3).
Confocal immunofluorescence in the AGM region and immu-
nohistochemistry in FL show the presence of Prep1 staining in
cells also expressing other markers of HSC like cKit and Sca1
(Figs. 1 and 2). Moreover, the demonstrated presence of Prep1 in
adult BM Sca1+Lin− cells (Fig. 4) also agrees with a role of
Prep1 in adult hematopoiesis. The presence of Prep1 in early
T-cell progenitors had already been documented (Penkov et al.,
2005).
Prep1 deficiency manifests with different degree of severity,
depending on the level of expression.Prep1 “null” embryos die at
E7.5 (Fernandez LC, Jenkins N, Copeland NG and Blasi F, in
preparation) while hypomorphic Prep1i/i embryos mostly die of
anemia at E17.5–P0 with a phenotype that is stronger in the
embryos producing less Prep1. The ability of one quarter of the
embryos to survive and live at least 16–18 months (Ferretti et al.,
2006) is likely due to the expression of slightly higher levels of
residual Prep1. This suggests that different Prep1 threshold levels
are required at different stages of the embryonic development.
The present analysis shows that the FL cells of Prep1i/i
embryos have a deficient radioprotective and competitive
repopulation activity but also present defects in the B-lymphoid
lineages. Interestingly, these data also show a dependence of the
B-lineage compartment differentiation on the Prep1 gene
dosage, as intermediate effects were observed in heterozygous
embryos (see Results).
The hematopoietic phenotypes of the Meis1 ko and of the
hypomorphic Prep1i/i embryos is very similar (deficient hema-
topoiesis, angiogenesis and oculogenesis) (Hisa et al., 2004;
Azcoitia et al., 2005; Ferretti et al., 2006). Since both proteins act
through a common mediator, Pbx, this is not really expected.
Prep1–Pbx andMeis1–Pbx dimersmight have different targets or
compensate for one another, hypotheses that are not in agreement
with so similar phenotypes. However, since Prep1 controls the
level of all Pbx and of Meis1 (Ferretti et al., 2006), the Prep1i/i
phenotype likely depends in part on the reduction of Pbx and
Meis1. Therefore, part of the Prep1i/i phenotype depends on the
reduction of Pbx and Meis1 levels. However, while Pbx1 was
shown to be required for B-lymphoid development at a stage
between hematopoietic stem cells and pro-B progenitors (Sanyal
et al., 2007), the low level expression of Prep1 appears to affect
not only differentiation of B-cells progenitors, but also earlier
precursors, starting from the LTR-HSC.
We conclude that Prep1 is an important player in the activity
of LTR-HSC and in the differentiation of the various progenitor
lineages. Prep1 not only directly participates in this pathway by
dimerizing with Pbx but also controls the expression of Pbx and
Meis, and hence it should also affect the activity and expression
of Hox and other genes regulating differentiation.
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